COMMUNIQUÉS West-GlobeNewswire

Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results
28/03/2018
BERKELEY HEIGHTS, N.J., March 28, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC ) (NASDAQ: CYCCP ) ("Cyclacel" or the "Company") a biopharmaceutical company developing oral therapies that target [...]
Menlo Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
28/03/2018
REDWOOD CITY, Calif., March 28, 2018 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO ), a late-stage biopharmaceutical company focused on the development of serlopitant, for the treatment of pruritus [...]
Ascendis Pharma A/S Reports Full Year 2017 Financial Results
28/03/2018
- Rare Disease Endocrinology Pipeline Advances, with Significant Milestones Anticipated Over the Next Twelve Months - - Conference Call Today at 4:30 p.m. Eastern Time - COPENHAGEN, Denmark, March 28, 2018 (GLOBE [...]
Veloxis Announces the Publication of ASERTAA (A Study of Extended Release Tacrolimus in African-Americans), a Phase IIIb study of ENVARSUS XR®
28/03/2018
Investor News no. 01/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 28 March 2018 Veloxis Announces the Publication of ASERTAA (A Study of Extended Release Tacrolimus in African-Americans), a Phase IIIb study of [...]
Northeast Scientific Receives 510K Clearance on Reprocessed RF Stylet
28/03/2018
WATERBURY, Conn., March 28, 2018 (GLOBE NEWSWIRE) -- Northeast Scientific, Inc. (NES), known for its advanced medical device reprocessing capability, received another 510K clearance from the FDA on 27 March, this time [...]
ICC Labs Announces Update to Terms of Investment with Strategic European Partner
28/03/2018
VANCOUVER, British Columbia , March 28, 2018 (GLOBE NEWSWIRE) -- ICC Labs Inc. (“ ICC Labs ” or the “ Company ”) (TSX-V: ICC ) (Frankfurt: 2Q9 ) is pleased to provide an update on its previously announced proposed [...]
OSE Immunotherapeutics: 2017 Annual Results and Clinical Advances of its Proprietary and Partnered Products
28/03/2018
Key Clinical Portfolio Development Progress Planned for 2018 Tedopi® (neoepitopes): Phase 3 clinical trial in NSCLC – Redeployment in the U.S., Europe and Israel, based on a revised protocol focused on patients who have [...]
Essilor: 2017 Registration Document Filed
28/03/2018
2017 Registration Document Filed PDF Version of the news release Charenton-le-Pont, France (March 28, 2018 - 6:00 pm CET) - The 2017 Essilor Registration Document was filed in French version with the Autorité des [...]
Essilor : Mise à disposition du Document de référence 2017
28/03/2018
Mise à disposition du Document de référence 2017 Version PDF du communiqué Charenton-le-Pont, France (le 28 mars 2018 - 18h00) - Le Document de référence 2017 d'Essilor a été déposé auprès de l'Autorité des Marchés [...]
Ossur Hf : Össur's total share capital
28/03/2018
Announcement no. 25/2018 Reykjavik, 28 March 2018 Össur's total share capital According to Article 84 of the Icelandic Act on Securities Transactions No. 108/2007, an issuer shall publish information on its total share [...]
Enrollment Completed in ADRESU Clinical Trial of Cytori Cell Therapy™ for Stress Urinary Incontinence
28/03/2018
SAN DIEGO and TOKYO, March 28, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ: CYTX ) announced today that full enrollment has been reached in the ADRESU investigator-initiated clinical trial of Cytori Cell [...]
Sienna Senior Living Inc. Completes Acquisition of Ten High-Quality Retirement Residences in Ontario
28/03/2018
MARKHAM, Ontario, March 28, 2018 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) is pleased to announce that it has completed the previously announced acquisition (the “ Acquisition ”) of [...]
Nicox : Assemblées Générales Ordinaire et Extraordinaire 2018
28/03/2018
Nicox : Assemblées Générales Ordinaire et Extraordinaire 2018 ............................................. 28 mars 2018 Sophia Antipolis, France Nicox SA (Euronext Paris : FR0013018124, COX, éligible PEA-PME), société [...]
Nicox: 2018 Extraordinary and Ordinary Shareholder Meetings
28/03/2018
Nicox: 2018 Extraordinary and Ordinary Shareholder Meetings ................................................ March 28, 2018 Sophia Antipolis, France Nicox SA (Euronext Paris: FR0013018124, COX), international [...]
Akers Biosciences Announces Rescheduled Conference Call to Discuss Fiscal Year 2017 Earnings
28/03/2018
THOROFARE, N.J., March 28, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, will now hold a conference [...]
The Alliance for Regenerative Medicine Releases Complete Agenda for Sixth Annual Cell & Gene Therapy Investor Day
28/03/2018
WASHINGTON, DC, March 28, 2018 (GLOBE NEWSWIRE) -- The Alliance for Regenerative Medicine (ARM) today released the complete agenda for its upcoming sixth annual Cell & Gene Therapy Investor Day, taking place April [...]
Organic & Natural Health Association Submits Petition to FDA for Vitamin D, Preterm Birth Health Claim
28/03/2018
WASHINGTON, March 28, 2018 (GLOBE NEWSWIRE) -- Organic & Natural Health Association submitted a petition to the FDA, requesting that the agency permit dietary supplements containing vitamin D to make a health claim [...]
Budget du Québec - Les ressources intermédiaires : Partenaires oubliés du gouvernement
28/03/2018
MONTRÉAL, 28 mars 2018 (GLOBE NEWSWIRE) -- L’Association des ressources intermédiaires d’hébergement du Québec (ARIHQ) se désole de l’absence de mesures pour répondre aux besoins grandissants des 14 000 personnes [...]
OncBioMune Returns Protocol to Scientific Review Committee Overseeing Phase 2 Prostate Cancer Clinical Trial
28/03/2018
BATON ROUGE, La., March 28, 2018 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary [...]

Pages